<DOC>
	<DOCNO>NCT02122822</DOCNO>
	<brief_summary>RATIONALE : heat shock protein gp96-peptide complex make person 's tumor cell may help body build effective immune response kill tumor cell . PURPOSE : This trial study safety effectiveness autologous gp96 treatment glioblastoma see well work treat patient newly diagnose supratentoria glioma .</brief_summary>
	<brief_title>Research Immunotherapy Glioblastoma With Autologous Heat Shock Protein gp96</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<criteria>1 . Able read understand inform consent document ; must sign informed consent . 2 . Aged 18 75 year old , sex limit 3 . Newly Diagnosed supratentoria glioma , Must undergone least 80 % resection 4 . Availability least 1 g tumor sample . 5 . Karnofsky functional status rating &gt; equal 70 . 6 . Adequate bone marrow function include absence lymphopenia ( ANC &gt; 1,500/ mm3 ; Hemoglobin &gt; 10g/dL ; platelet count &gt; 100,000/mm3 ) , adequate liver function ( serum glutamic oxaloacetic transaminase/ aspartate aminotransferase [ AST ] , alanine amino transferase [ ALT ] &lt; 2.5 time institutional upper limit normal [ IULNs ] ) , adequate renal function ( BUN creatinine &lt; 1.5 time IULNs ) 7 . Agree Surgical indication Heart &amp; lung without coagulation system disease 8 . Negative pregnancy test female patient childbearing potential 9 . Agree use contraception abstain sexual activity time consent 3 month end study drug administration 1 . Inability comply studyrelated procedure 2. patient suitable Neurosurgery . 3 . Unavailability least 6 dos vaccine 4 . Progression prior vaccination determine Principal Investigator 5 . Patient allergic constitution 6 . Unstable severe intercurrent medical condition 7 . Current diagnosis Human Immunodeficiency Virus Patients active uncontrolled infection . 8. patient systemic disease need treat immunosuppressant Corticosteroids . 9. clinical trial within 30 day prevaccination . 10 . Female patient pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>supratentoria glioma</keyword>
</DOC>